Dr. Kartik Konduri, MD
What this data tells you about Dr. Konduri
Dr. Kartik Konduri is a hematology & oncology in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. Konduri performed 96,810 Medicare services across 3,286 unique beneficiaries.
Between the years covered by Open Payments, Dr. Konduri received a total of $183,738 from 25 pharmaceutical and/or device companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Konduri is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 23,300 | $43 | $137 |
| Anti-nausea injection (fosaprepitant) | 19,350 | $0 | $5 |
| Paclitaxel chemotherapy injection | 11,864 | $0 | $8 |
| Contrast dye for imaging (iodine-based) | 10,595 | $0 | $3 |
| Iron infusion (Feraheme) | 8,670 | $0 | $5 |
| Daratumumab injection (Darzalex) | 4,680 | $38 | $126 |
| Dexamethasone injection (steroid) | 2,985 | $0 | $1 |
| Injection, docetaxel, 1 mg | 2,226 | $0 | $66 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,801 | $1 | $115 |
| Denosumab injection (Prolia/Xgeva) | 1,560 | $19 | $66 |
| Injection, granisetron hydrochloride, 100 mcg | 1,010 | $0 | $24 |
| Comprehensive metabolic blood panel | 829 | $10 | $64 |
| Complete blood count (CBC) with differential | 813 | $8 | $36 |
| Blood draw (venipuncture) | 801 | $8 | $20 |
| Office visit, established patient (30-39 min) | 694 | $97 | $368 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 608 | $23 | $157 |
| Administration of chemotherapy into vein, 1 hour or less | 446 | $104 | $707 |
| Injection, leucovorin calcium, per 50 mg | 386 | $3 | $25 |
| Injection, carboplatin, 50 mg | 385 | $2 | $300 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 380 | $3 | $373 |
| Injection of additional new drug or substance into vein | 363 | $12 | $108 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 324 | $82 | $1,348 |
| Injection, fluorouracil, 500 mg | 273 | $2 | $13 |
| Office visit, established patient (20-29 min) | 237 | $68 | $250 |
| Injection, magnesium sulfate, per 500 mg | 180 | $1 | $6 |
| Injection, diphenhydramine hcl, up to 50 mg | 154 | $1 | $7 |
| Injection, zoledronic acid, 1 mg | 153 | $6 | $431 |
| Administration of additional new drug or substance into vein, 1 hour or less | 127 | $51 | $344 |
| Injection, cisplatin, powder or solution, 10 mg | 127 | $2 | $94 |
| Hospital follow-up visit, moderate complexity | 110 | $62 | $247 |
| Ct scan of chest with contrast | 102 | $53 | $821 |
| Unclassified drugs | 101 | $1 | $8 |
| Administration of chemotherapy into vein, each additional hour | 93 | $22 | $161 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 91 | $50 | $313 |
| CT scan of abdomen and pelvis with contrast | 85 | $179 | $1,067 |
| Infusion, normal saline solution , 1000 cc | 81 | $2 | $19 |
| Drug injection, under skin or into muscle | 78 | $11 | $96 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 70 | $57 | $211 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 54 | $16 | $94 |
| CT scan of chest, without contrast | 52 | $61 | $686 |
| Reticulated (young) platelet measurement | 44 | $31 | $143 |
| Infusion into a vein for hydration, each additional hour | 44 | $10 | $75 |
| Hospital follow-up visit, low complexity | 40 | $39 | $135 |
| Administration of chemotherapy into vein using push technique | 38 | $81 | $500 |
| Office visit, established patient, complex (40-54 min) | 38 | $140 | $496 |
| Administration of additional new drug or substance into vein using push technique | 33 | $44 | $289 |
| Microscopic examination for white blood cells with manual cell count | 31 | $4 | $22 |
| Complete blood count (CBC), automated | 31 | $6 | $34 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 30 | $16 | $100 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 28 | $133 | $500 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 27 | $1,187 | $4,802 |
| Application of on-body injector for under skin injection | 27 | $15 | $96 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 26 | $89 | $657 |
| Irrigation of implanted venous access drug delivery device | 23 | $18 | $114 |
| Ct scan of soft tissue of neck with contrast | 21 | $63 | $658 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 20 | $1 | $17 |
| New patient office visit (45-59 min) | 19 | $132 | $565 |
| Blood creatinine level | 15 | $5 | $31 |
| Basic metabolic blood panel | 14 | $8 | $49 |
| Urinalysis with microscopic exam | 12 | $3 | $28 |
| Office visit, established patient (10-19 min) | 11 | $41 | $150 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (53%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for hematology & oncology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Konduri is a mixed practice specialist, with above-average Medicare volume (top 8% in TX), and high industry engagement (consulting-driven, top 4%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Konduri experienced with pembrolizumab injection (keytruda)?
Does Dr. Konduri receive payments from pharmaceutical companies?
How do Dr. Konduri's costs compare to other hematology & oncologys in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology